D07.4
Carcinoma in situ of penis
Clinical Classification Guidelines
Inclusion Terms
- Erythroplasia of Queyrat NOS
Medical Intelligence & Overview
Carcinoma in situ of the penis, also known as erythroplasia of Queyrat, is an early form of penile cancer where abnormal cells are found on the surface of the penile tissue. As a non-invasive condition, it is confined to the top layer of skin and has not yet spread to deeper tissues or other parts of the body. Recognizing and treating this condition promptly is crucial to prevent progression to invasive cancer.
Causes & Symptoms
Clinical Causes: Chronic irritation or inflammation of the penile skin Human papillomavirus (HPV) infection, especially high-risk strains Poor personal hygiene Infrequent or lack of circumcision History of other sexually transmitted infections Smoking, which can impair immune response Immunosuppression, such as in HIV infection or organ transplant recipients
Key Symptoms: Red, velvety, or scaly patches on the penile skin, often on the glans or foreskin Lumps or raised lesions that may be tender or ulcerated Color changes, such as erythema or reddish patches Persistent sores or ulcers that do not heal In some cases, no symptoms are apparent, and the condition is found during routine examinations
Diagnostic & Treatment
Diagnosis Path: Diagnosis of carcinoma in situ of the penis typically involves a combination of physical examination, patient history, and laboratory tests. A biopsy of the affected tissue is essential for confirming the presence of abnormal cells and distinguishing carcinoma in situ from benign conditions or invasive cancer. Additional procedures such as dermoscopy or imaging may help assess the extent of the lesion. The diagnosis also involves ruling out other conditions with similar presentations, such as penile psoriasis or infections.
Treatment Protocols: Treatment options focus on eradicating the abnormal cells and preventing progression to invasive cancer. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is D07.4 a billable ICD-10 code?
Yes, D07.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D07.4?
Clinical documentation must specify the nature of Carcinoma in situ of penis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
